Golden
Ridgeback Capital

Ridgeback Capital

Ridgeback Capital is a New York based investment firm which seeks long term investments in healthcare and life sciences.

Ridgeback Capital is a New York City, New York based investment firm. They seek investments in healthcare and life science sectors.They make long term investments in private and public companies Ridgeback Capital feels are dedicated to developing life saving and life changing therapies with which they feel patient capital is vital.



Investment

Ridgeback Capital has invested in Harpoon Therapeutics, 4D Molecular Therapeutics, Precision BioSciences, Selecta Biosciences, Adaptimmune, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia, Alveolus and Nested.



Ridgeback Capital has exited from investments in Precision BioSciences, Adaptimmune, Harpoon Therapeutics, Selecta Biosciences, Bellicum Pharmaceuticals, Stem Cell Therapeutics, Microbia and Alveolus.

Timeline

Funded Companies

3 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.

4D Molecular Therapeutics designs, develops and commercializes products for gene therapy.

Nested is a London-based company.

People

Name
Role
LinkedIn

Dr. Wayne Holman

Founder



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References